These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 89849)

  • 41. Measurement of disposition half-life, clearance, and residence times.
    Mayersohn M
    Curr Protoc Toxicol; 2001 May; Chapter 5():Unit5.3. PubMed ID: 20949436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic and kinetic aspects of toxicological studies. 19 May 1987, Paris, France.
    Xenobiotica; 1988 Jan; 18 Suppl 1():1-96. PubMed ID: 3344587
    [No Abstract]   [Full Text] [Related]  

  • 43. [Species differences in pharmaco-kinetics of chemicals. Correlations with toxicity (author's transl)].
    Keck G
    Toxicol Eur Res; 1981 Jul; 3(4):207-15. PubMed ID: 7302948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Iteration program for determining pharmacokinetic constants with a digital computer (author's transl)].
    Lücker PW
    Arzneimittelforschung; 1977; 27(12):2371-2. PubMed ID: 580053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Altered pharmacokinetics in old age: consequences for cytostatic therapy].
    Gribnau FW
    Tijdschr Gerontol Geriatr; 1986 Apr; 17(2):55-8. PubMed ID: 3715963
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
    Lesne M
    J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
    [No Abstract]   [Full Text] [Related]  

  • 48. The use of computers in pharmacokinetics.
    Danek A
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):345-50. PubMed ID: 689793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pharmacokinetics and dosage regimen in children (author's transl)].
    Gladtke E
    Monatsschr Kinderheilkd (1902); 1979 Apr; 127(4):166-70. PubMed ID: 449872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [First-past Effect (author's transl)].
    Leopold G
    Arzneimittelforschung; 1977 Feb; 27(2A):241-9. PubMed ID: 577169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comments on "an improvement on the Wagner-Nelson method for computing drug absorption rate constant" (author's transl)].
    Ping QN
    Yao Xue Xue Bao; 1982 Feb; 17(2):98-100. PubMed ID: 7102328
    [No Abstract]   [Full Text] [Related]  

  • 52. The Role of Extracellular Binding Proteins in the Cellular Uptake of Drugs: Impact on Quantitative In Vitro-to-In Vivo Extrapolations of Toxicity and Efficacy in Physiologically Based Pharmacokinetic-Pharmacodynamic Research.
    Poulin P; Burczynski FJ; Haddad S
    J Pharm Sci; 2016 Feb; 105(2):497-508. PubMed ID: 26173749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exploration of PBPK Model-Calculation of Drug Time Course in Tissue Using IV Bolus Drug Plasma Concentration-Time Profile and the Physiological Parameters of the Organ.
    Berezhkovskiy LM
    J Pharm Sci; 2016 Aug; 105(8):2453-8. PubMed ID: 27290628
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Circadian rhythms in metabolism and susceptibility of drugs (author's transl)].
    Kato R; Muraki T
    Tanpakushitsu Kakusan Koso; 1982 Jan; 27(2):158-69. PubMed ID: 7041179
    [No Abstract]   [Full Text] [Related]  

  • 55. The use of pharmacokinetics as an interpretive and predictive tool in chemical toxicology testing and risk assessment: a position paper on the appropriate use of pharmacokinetics in chemical toxicology.
    Frantz SW; Beatty PW; English JC; Hundley SG; Wilson AG
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):317-37. PubMed ID: 8090955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Methodological aspects of the evaluation of the binding of drugs to plasma and tissue proteins.
    Tillement JP; Albengres E; Urien S
    Eur J Drug Metab Pharmacokinet; 1979; 4(3):123-7. PubMed ID: 393513
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)].
    Heinzel G; Hammer R; Wolf M; Koss FW; Bozler G
    Arzneimittelforschung; 1977; 27(4a):904-11. PubMed ID: 577858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The state of the art: a commentary on the current practice of metabolism and pharmacokinetic studies in the pharmaceutical industry.
    Case DE
    Xenobiotica; 1981 Dec; 11(12):803-14. PubMed ID: 7342486
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Receptor occupation theory and its parameter estimates (author's transl)].
    Xu DZ
    Sheng Li Ke Xue Jin Zhan; 1981 Oct; 12(4):318-24. PubMed ID: 7344074
    [No Abstract]   [Full Text] [Related]  

  • 60. Using pharmacokinetics in drug therapy II: Rapid estimates of dosage regimens and blood levels without knowledge of pharmacokinetic variables.
    Schumacher GE; Griener JC
    Am J Hosp Pharm; 1978 Apr; 35(4):454-9. PubMed ID: 645719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.